Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 5, 2013, Pages 1646-1651

  Matsushita, Chihiro ^a   Tamagaki, Hiroko ^a   Miyazawa, Yudai ^a   Aimoto, Saburo ^a   Smith, Steven O ^b   Sato, Takeshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

EGF receptor; HER2 receptor; PIP2

Indexed keywords

DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MEMBRANE PROTEIN; PEPTIDE; PROTEIN TYROSINE KINASE;

ARTICLE; BILAYER MEMBRANE; ENZYME ACTIVATION; INTRACELLULAR MEMBRANE; JUXTAMEMBRANE SEQUENCE; LIGAND BINDING; MEMBRANE BINDING; MEMBRANE STRUCTURE; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; TRANSMEMBRANE DOMAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CALMODULIN; KINETICS; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTOR, ERBB-2; SPECTROMETRY, FLUORESCENCE;

EID: 84873181474     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1215207110     Document Type: Article

References (44)

1. Hubbard SR, Till JH (2000) Protein tyrosine kinase structure and function. Annu Rev Biochem 69:373-398.
2. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103(2):211-225.
3. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411(6835):355-365. (Pubitemid 32467045)
4. Holbro T, Civenni G, Hynes NE (2003) The ErbB receptors and their role in cancer progression. Exp Cell Res 284(1):99-110. (Pubitemid 36331969)
5. Ogiso H, et al. (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110(6):775-787. (Pubitemid 35291060)
6. Ferguson KM, et al. (2003) EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11(2):507-517. (Pubitemid 36297057)
7. Stamos J, Sliwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277(48):46265-46272. (Pubitemid 35417619)
8. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J (2006) An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125(6):1137-1149. (Pubitemid 43866200)
9. Bargmann CI, Hung MC, Weinberg RA (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45(5):649-657. (Pubitemid 16063129)
10. Bargmann CI, Weinberg RA (1988) Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene. Proc Natl Acad Sci USA 85(15):5394-5398.
11. Bargmann CI, Hung MC, Weinberg RA (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319(6050):226-230. (Pubitemid 16128785)
12. Bargmann CI, Weinberg RA (1988) Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J 7(7):2043-2052.
13. Smith SO, Smith CS, Bormann BJ (1996) Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor. Nat Struct Biol 3(3):252-258. (Pubitemid 26081708)
14. Burke CL, Lemmon MA, Coren BA, Engelman DM, Stern DF (1997) Dimerization of the p185neu transmembrane domain is necessary but not sufficient for transformation. Oncogene 14(6):687-696. (Pubitemid 27095860)
15. Mattoon D, Gupta K, Doyon J, Loll PJ, Di Maio D (2001) Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein. Oncogene 20(29):3824-3834. (Pubitemid 32646193)
16. Seubert N, et al. (2003) Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol Cell 12(5):1239-1250. (Pubitemid 37487931)
17. Staerk J, et al. (2011) Orientation-specific signalling by thrombopoietin receptor dimers. EMBO J 30(21):4398-4413.
18. Smith SO, et al. (2002) Transmembrane interactions in the activation of the Neu receptor tyrosine kinase. Biochemistry 41(30):9321-9332. (Pubitemid 34810006)
19. McLaughlin S, Smith SO, Hayman MJ, Murray D (2005) An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family. J Gen Physiol 126(1):41-53. (Pubitemid 40994107)
20. Sengupta P, et al. (2009) EGFR juxtamembrane domain, membranes, and calmodulin: Kinetics of their interaction. Biophys J 96(12):4887-4895.
21. Liu W, Crocker E, Constantinescu SN, Smith SO (2005) Helix packing and orientation in the transmembrane dimer of gp55-P of the spleen focus forming virus. Biophys J 89(2):1194-1202. (Pubitemid 41099001)
22. Michailidis IE, et al. (2011) Phosphatidylinositol-4, 5-bisphosphate regulates epidermal growth factor receptor activation. Pflugers Archivy. Eur J Phys 461(3):387-397.
23. McLaughlin S, Wang JY, Gambhir A, Murray D (2002) PIP (2) and proteins: Interactions, organization, and information flow. Annu Rev Biophys Biomol Struct 31:151-175.
24. Van Den Bogaart G, et al. (2011) Membrane protein sequestering by ionic protein-lipid interactions. Nature 479(7374):552-555.
25. Clayton A H A, Tavarnesi ML, Johns TG (2007) Unligated epidermal growth factor receptor forms higher order oligomers within microclusters on A431 cells that are sensitive to tyrosine kinase inhibitor binding. Biochemistry 46(15):4589-4597. (Pubitemid 46625515)
26. Nowacka A, Mohr PC, Norrman J, Martin RW, Topgaard D (2010) Polarization transfer solid-state NMR for studying surfactant phase behavior. Langmuir 26(22):16848-16856.
27. Zhong L, Bamm VV, Ahmed M A M, Harauz G, Ladizhansky V (2007) Solid-state NMR spectroscopy of 18.5 kDa myelin basic protein reconstituted with lipid vesicles: Spectroscopic characterisation and spectral assignments of solvent-exposed protein fragments. Biochim Biophys. Acta-Biomembr 1768(12):3193-3205. (Pubitemid 350236084)
28. Cao H, Bangalore L, Bormann BJ, Stern DF (1992) A subdomain in the transmembrane domain is necessary for p185neu* activation. EMBO J 11(3):923-932.
29. Bell CA, et al. (2000) Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase. Mol Biol Cell 11(10):3589-3599.
30. Macdonald-Obermann JL, Pike LJ (2009) Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding. Biochemistry 48(11):2505-2513.
31. Macdonald-Obermann JL, Pike LJ (2009) The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding. J Biol Chem 284(20):13570-13576.
32. Mendrola JM, Berger MB, King MC, Lemmon MA (2002) The single transmembrane domains of ErbB receptors self-associate in cell membranes. J Biol Chem 277(7):4704-4712. (Pubitemid 34968501)
33. Duneau JP, Vegh AP, Sturgis JN (2007) A dimerization hierarchy in the transmembrane domains of the HER receptor family. Biochemistry 46(7):2010-2019. (Pubitemid 46290552)
34. Beevers AJ, Damianoglou A, Oates J, Rodger A, Dixon AM (2010) Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant. Biochemistry 49(13):2811-2820.
35. Bocharov EV, et al. (2008) Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state. J Biol Chem 283(11):6950-6956.
36. Sorokin A (1995) Activation of the EGF receptor by insertional mutations in its juxtamembrane regions. Oncogene 11(8):1531-1540.
37. Jura N, et al. (2009) Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137(7):1293-1307.
38. Kashles O, et al. (1988) Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions. Proc Natl Acad Sci USA 85(24):9567-9571. (Pubitemid 19027168)
39. Carpenter CD, et al. (1991) Structural analysis of the transmembrane domain of the epidermal growth factor receptor. J Biol Chem 266(9):5750-5755.
40. Sternberg MJ, Gullick WJ (1990) A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization. Protein Eng 3(4):245-248. (Pubitemid 20133624)
41. Chung I, et al. (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464(7289):783-787.
42. 2+/calmodulin. Biochemistry 45(42):12704-12714. (Pubitemid 44630856)
43. Hake MJ, Choowongkomon K, Kostenko O, Carlin CR, Sönnichsen FD (2008) Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor. Biochemistry 47(10):3096-3108. (Pubitemid 351364903)
44. Kil SJ, Carlin C (2000) EGF receptor residues leu679, leu680 mediate selective sorting of ligand-receptor complexes in early endosomal compartments. J Cell Physiol 185(1):47-60.